MDM2 chaperones the p53 tumor suppressor.

Area of Science:

• Molecular Biology
• Biochemistry
• Oncology

Background:

• The murine double minute 2 (MDM2) gene encodes an E3 ubiquitin ligase critical for p53 tumor suppressor degradation.
• Emerging evidence suggests MDM2 has functions beyond p53 regulation, including ATP binding, Hsp90 interaction, and roles in transcription, DNA polymerase activity, and ribosome assembly.

Purpose of the Study:

• To investigate the potential intrinsic molecular chaperone activity of the MDM2 protein.
• To elucidate the role of MDM2's ATP-binding function in its chaperone activity toward p53.

Main Methods:

• Assessed MDM2's ability to substitute for Hsp90 in facilitating p53 binding to the p21 promoter.
• Utilized ATP binding and zinc-coordinating residue mutants of MDM2 (K454A, C478S, C464A) to evaluate chaperone function in vitro and in vivo.
• Co-transfected wild-type p53 with various MDM2 constructs in H1299 cells.

Main Results:

• MDM2 exhibits intrinsic molecular chaperone activity, promoting p53 folding and binding to the p21 promoter.
• ATP binding to MDM2 is essential for its chaperone function, as demonstrated by the loss of activity in the K454A mutant.
• Mutations in zinc-coordinating residues (C478S, C464A) inhibited p53 degradation while enhancing folding, further supporting MDM2's chaperone role.

Conclusions:

• MDM2 possesses a novel intrinsic molecular chaperone activity.
• The ATP-binding capability of MDM2 is a key mediator of its chaperone function towards the p53 tumor suppressor.
• These findings reveal a dual role for MDM2 in regulating p53 stability and function through both degradation and chaperone-mediated processes.